Chloroquine dihydrochloride
| Code | Size | Price |
|---|
| TAR-T0194L2-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Chloroquine is a medication preventing and treating malaria in areas where malaria is known to be sensitive to its effects. It is also sometimes used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. Chloroquine enters the red blood cell, inhibiting the parasite cell and digestive vacuole by simple diffusion.
CAS:
3545-67-3
Formula:
C18H28Cl3N3
Molecular Weight:
392.79
Purity:
0.98
SMILES:
Cl.Cl.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
References
1. Tong Y, Zhang G, Li Y, Xu J, Yuan J, Zhang B, Hu T, Song G. Corilagin inhibits breast cancer growth via reactive oxygen species-dependent apoptosis and autophagy. J Cell Mol Med. 2018 Jun 19. doi: 10.1111/jcmm.13647. [Epub ahead of print] PubMed PMID: 29923307.
2. Mart?n-D?vila P, Norman F, Fort?n-Abete J, P?ris M, Lovatti R, Rubio JM, Martinez-P?rez A, Graus J, Ta G, Villarubia J, Mahillo B, L?pez-V?lez R. Donor-derived multiorgan transmission of mixed P. malariae and P. ovale infection: Impact of globalization on post-transplant infections. Transpl Infect Dis. 2018 Jun 4:e12938. doi: 10.1111/tid.12938. [Epub ahead of print] PubMed PMID: 29863799.
3. Long HL, Zhang FF, Wang HL, Yang WS, Hou HT, Yu JK, Liu B. Mulberry anthocyanins improves thyroid cancer progression mainly by inducing apoptosis and autophagy cell death. Kaohsiung J Med Sci. 2018 May;34(5):255-262. doi: 10.1016/j.kjms.2017.11.004. Epub 2017 Dec 6. PubMed PMID: 29699632.
4. Elsakka AMA, Bary MA, Abdelzaher E, Elnaggar M, Kalamian M, Mukherjee P, Seyfried TN. Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up. Front Nutr. 2018 Mar 29;5:20. doi: 10.3389/fnut.2018.00020. eCollection 2018. PubMed PMID: 29651419; PubMed Central PMCID: PMC5884883.